CURE CANCER @ UCL CANCER INSTITUTE
Promoting awareness and raising funds to enable the charity to purchase capital equipment and consumables for the UCL Cancer Institute.
Objects
TO RELIEVE SICKNESS AND TO PROMOTE AND PROTECT GOOD HEALTH BY FUNDING RESEARCH FOR THE PUBLIC BENEFIT AT UCL AND OTHER INSTITUTIONS INTO LYMPHOMAS, OTHER CANCERS AND RELATED DISEASES AND THE MEANT TO CONTROL, MANAGE AND CURE THEM AND TO DISSEMINATE THE USEFUL RESULTS TO THE PUBLIC
Financial health, per its FY2026 accounts
The accounts state that unrestricted reserves decreased from £32,665 to £23,042 due to charitable expenditure exceeding income. The trustees confirm the charity remains in a stable financial position and has adequate resources to continue in operational existence for the foreseeable future.
What the accounts disclose
“Charitable activities 4 30,706” — page 8
Policies the charity declares
- Internal charity financial controls policy and procedures
Trustees
- JULIAN MARGOLIN
- NATASHA HAMILTON
- SANDRA HAMILTON
- STEPHEN SAMPSON
- Siamack Bagheri
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/03/2026 | £39k | £48k |
| 31/03/2025 | £40k | £95k |
| 31/03/2024 | £27k | £7k |
| 31/03/2023 | £51k | £8k |
| 31/03/2022 | £29k | £23k |
Common questions
Is CURE CANCER @ UCL CANCER INSTITUTE financially healthy?
Per its FY2026 accounts: The accounts state that unrestricted reserves decreased from £32,665 to £23,042 due to charitable expenditure exceeding income. The trustees confirm the charity remains in a stable financial position and has adequate resources to continue in operational existence for the foreseeable future. Its FY2026 accounts were independently examined.